vs
布鲁克（BRKR）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是布鲁克的1.5倍（$1.4B vs $977.2M），瑞思迈净利率更高（27.6% vs 2.7%，领先24.9%），瑞思迈同比增速更快（11.0% vs -0.2%），过去两年布鲁克的营收复合增速更高（16.4% vs 7.9%）
布鲁克公司是美国科学仪器制造商，总部位于马萨诸塞州比勒里卡，为公开上市企业。公司产品服务于分子与材料研究、工业及应用分析领域，旗下设有布鲁克科学仪器、布鲁克能源与超导技术（BEST）两大业务板块。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
BRKR vs RMD — 直观对比
营收规模更大
RMD
是对方的1.5倍
$977.2M
营收增速更快
RMD
高出11.2%
-0.2%
净利率更高
RMD
高出24.9%
2.7%
两年增速更快
BRKR
近两年复合增速
7.9%
损益表 — Q4 FY2025 vs Q4 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $977.2M | $1.4B |
| 净利润 | $26.0M | $392.6M |
| 毛利率 | 46.0% | 61.8% |
| 营业利润率 | 7.8% | 34.6% |
| 净利率 | 2.7% | 27.6% |
| 营收同比 | -0.2% | 11.0% |
| 净利润同比 | 89.8% | 13.9% |
| 每股收益（稀释后） | $0.10 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BRKRRMD
| Q2 26 | — | $1.4B | ||
| Q4 25 | $977.2M | $1.4B | ||
| Q3 25 | $860.5M | $1.3B | ||
| Q2 25 | $797.4M | $1.3B | ||
| Q1 25 | $801.4M | $1.3B | ||
| Q4 24 | $979.6M | $1.3B | ||
| Q3 24 | $864.4M | $1.2B | ||
| Q2 24 | $800.7M | $1.2B |
净利润BRKRRMD
| Q2 26 | — | $392.6M | ||
| Q4 25 | $26.0M | $392.6M | ||
| Q3 25 | $-59.6M | $348.5M | ||
| Q2 25 | $7.6M | $379.7M | ||
| Q1 25 | $17.4M | $365.0M | ||
| Q4 24 | $13.7M | $344.6M | ||
| Q3 24 | $40.9M | $311.4M | ||
| Q2 24 | $7.6M | $292.2M |
毛利率BRKRRMD
| Q2 26 | — | 61.8% | ||
| Q4 25 | 46.0% | 61.8% | ||
| Q3 25 | 44.1% | 61.5% | ||
| Q2 25 | 44.9% | 60.8% | ||
| Q1 25 | 48.8% | 59.3% | ||
| Q4 24 | 50.4% | 58.6% | ||
| Q3 24 | 48.4% | 58.6% | ||
| Q2 24 | 48.0% | 58.5% |
营业利润率BRKRRMD
| Q2 26 | — | 34.6% | ||
| Q4 25 | 7.8% | 34.6% | ||
| Q3 25 | -6.0% | 33.4% | ||
| Q2 25 | 1.5% | 33.7% | ||
| Q1 25 | 4.0% | 33.0% | ||
| Q4 24 | 7.4% | 32.5% | ||
| Q3 24 | 7.9% | 31.6% | ||
| Q2 24 | 6.0% | 31.2% |
净利率BRKRRMD
| Q2 26 | — | 27.6% | ||
| Q4 25 | 2.7% | 27.6% | ||
| Q3 25 | -6.9% | 26.1% | ||
| Q2 25 | 1.0% | 28.2% | ||
| Q1 25 | 2.2% | 28.3% | ||
| Q4 24 | 1.4% | 26.9% | ||
| Q3 24 | 4.7% | 25.4% | ||
| Q2 24 | 0.9% | 23.9% |
每股收益（稀释后）BRKRRMD
| Q2 26 | — | $2.68 | ||
| Q4 25 | $0.10 | $2.68 | ||
| Q3 25 | $-0.41 | $2.37 | ||
| Q2 25 | $0.05 | $2.58 | ||
| Q1 25 | $0.11 | $2.48 | ||
| Q4 24 | $0.09 | $2.34 | ||
| Q3 24 | $0.27 | $2.11 | ||
| Q2 24 | $0.05 | $1.97 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $298.8M | $1.4B |
| 总债务越低越好 | $1.9B | $663.8M |
| 股东权益账面价值 | $2.5B | $6.3B |
| 总资产 | $6.2B | $8.5B |
| 负债/权益比越低杠杆越低 | 0.76× | 0.11× |
8季度趋势，按日历期对齐
现金及短期投资BRKRRMD
| Q2 26 | — | $1.4B | ||
| Q4 25 | $298.8M | $1.4B | ||
| Q3 25 | $293.1M | $1.4B | ||
| Q2 25 | $92.0M | $1.2B | ||
| Q1 25 | $184.2M | $932.7M | ||
| Q4 24 | $183.4M | $521.9M | ||
| Q3 24 | $148.1M | $426.4M | ||
| Q2 24 | $169.7M | $238.4M |
总债务BRKRRMD
| Q2 26 | — | $663.8M | ||
| Q4 25 | $1.9B | $403.9M | ||
| Q3 25 | $2.0B | $408.7M | ||
| Q2 25 | $2.4B | $658.4M | ||
| Q1 25 | $2.1B | $663.1M | ||
| Q4 24 | $2.1B | $662.9M | ||
| Q3 24 | $2.3B | $667.6M | ||
| Q2 24 | $2.2B | $697.3M |
股东权益BRKRRMD
| Q2 26 | — | $6.3B | ||
| Q4 25 | $2.5B | $6.3B | ||
| Q3 25 | $2.4B | $6.1B | ||
| Q2 25 | $1.8B | $6.0B | ||
| Q1 25 | $1.8B | $5.5B | ||
| Q4 24 | $1.8B | $5.3B | ||
| Q3 24 | $1.8B | $5.2B | ||
| Q2 24 | $1.8B | $4.9B |
总资产BRKRRMD
| Q2 26 | — | $8.5B | ||
| Q4 25 | $6.2B | $8.5B | ||
| Q3 25 | $6.4B | $8.3B | ||
| Q2 25 | $6.3B | $8.2B | ||
| Q1 25 | $5.9B | $7.6B | ||
| Q4 24 | $5.8B | $7.1B | ||
| Q3 24 | $6.1B | $7.2B | ||
| Q2 24 | $5.9B | $6.9B |
负债/权益比BRKRRMD
| Q2 26 | — | 0.11× | ||
| Q4 25 | 0.76× | 0.06× | ||
| Q3 25 | 0.83× | 0.07× | ||
| Q2 25 | 1.34× | 0.11× | ||
| Q1 25 | 1.15× | 0.12× | ||
| Q4 24 | 1.18× | 0.13× | ||
| Q3 24 | 1.27× | 0.13× | ||
| Q2 24 | 1.21× | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $229.8M | — |
| 自由现金流经营现金流 - 资本支出 | $207.2M | — |
| 自由现金流率自由现金流/营收 | 21.2% | — |
| 资本支出强度资本支出/营收 | 2.3% | — |
| 现金转化率经营现金流/净利润 | 8.84× | — |
| 过去12个月自由现金流最近4个季度 | $43.3M | — |
8季度趋势，按日历期对齐
经营现金流BRKRRMD
| Q2 26 | — | — | ||
| Q4 25 | $229.8M | $339.7M | ||
| Q3 25 | $-33.2M | $457.3M | ||
| Q2 25 | $-127.5M | $538.8M | ||
| Q1 25 | $65.0M | $578.7M | ||
| Q4 24 | $190.0M | $308.6M | ||
| Q3 24 | $38.4M | $325.5M | ||
| Q2 24 | $1.1M | $440.1M |
自由现金流BRKRRMD
| Q2 26 | — | — | ||
| Q4 25 | $207.2M | $311.2M | ||
| Q3 25 | $-54.1M | $414.4M | ||
| Q2 25 | $-148.8M | $508.2M | ||
| Q1 25 | $39.0M | $557.9M | ||
| Q4 24 | $153.3M | $288.0M | ||
| Q3 24 | $5.8M | $307.7M | ||
| Q2 24 | $-23.5M | $415.2M |
自由现金流率BRKRRMD
| Q2 26 | — | — | ||
| Q4 25 | 21.2% | 21.9% | ||
| Q3 25 | -6.3% | 31.0% | ||
| Q2 25 | -18.7% | 37.7% | ||
| Q1 25 | 4.9% | 43.2% | ||
| Q4 24 | 15.6% | 22.5% | ||
| Q3 24 | 0.7% | 25.1% | ||
| Q2 24 | -2.9% | 33.9% |
资本支出强度BRKRRMD
| Q2 26 | — | — | ||
| Q4 25 | 2.3% | 2.0% | ||
| Q3 25 | 2.4% | 3.2% | ||
| Q2 25 | 2.7% | 2.3% | ||
| Q1 25 | 3.2% | 1.6% | ||
| Q4 24 | 3.7% | 1.6% | ||
| Q3 24 | 3.8% | 1.5% | ||
| Q2 24 | 3.1% | 2.0% |
现金转化率BRKRRMD
| Q2 26 | — | — | ||
| Q4 25 | 8.84× | 0.87× | ||
| Q3 25 | — | 1.31× | ||
| Q2 25 | -16.78× | 1.42× | ||
| Q1 25 | 3.74× | 1.59× | ||
| Q4 24 | 13.87× | 0.90× | ||
| Q3 24 | 0.94× | 1.05× | ||
| Q2 24 | 0.14× | 1.51× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BRKR
| Bsi Nano | $309.1M | 32% |
| Bsi Biospin | $267.0M | 27% |
| Other | $179.9M | 18% |
| Transferred Over Time | $142.5M | 15% |
| Energy And Supercon Technologies | $69.5M | 7% |
RMD
暂无分部数据
